30261916|t|Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease.
30261916|a|Following publication of the original article [1], the author reported errors in the formatting of the table. The details of the errors are as follows.
30261916	47	59	gantenerumab	Chemical	MESH:C571128
30261916	73	92	Alzheimer's disease	Disease	MESH:D000544
30261916	Negative_Correlation	MESH:C571128	MESH:D000544

